On Mar 14, 2022 Nutcracker Therapeutics closed a Series C round and raised $167,000,000 from ARCH Venture Partners, featuring lead investors ARCH Venture Partners.
About the company: Nutcracker Therapeutics is located at United States, North America.
“”
Company website: http://www.nutcrackerx.com